Drug of Abuse Testing Market Research Report- Global Forecast to 2020

Drug of Abuse Testing Market Research Report- Global Forecast to 2020

ID: MRFR/HC/1398-CRR | January, 2017 | Region: Global | 66 pages | Cooked Research Reports

Drug of Abuse Testing Market Information, by Test type (Onsite Screening Test, Laboratory Drug Testing), by Sample (Urine, Hair, Saliva) - Forecast to 2020


Market Synopsis of Drug of Abuse Testing Market:


Market Scenario:


Drug of abuse testing is based on diagnosing drug addiction, also called substance use disorder, requiring a thorough evaluation and often includes an assessment by a psychiatrist, a psychologist, or a licensed alcohol and drug counselor. Blood, urine or other lab tests are used to assess drug use, but they're not a diagnostic test for addiction. These tests may be used for monitoring treatment. The factor which may influence the growth of the drug of abuse testing market is increased use of drug testing at organizational level, increased production and trade of illicit drugs worldwide and others. Globally the market for drug of abuse testing is expected to grow at 5.3% GAGR from 2016 to 2020.


Drug of Abuse Testing Market, by Sample (%)


Drug of Abuse Testing Market, by Sample (%)


Intended Audience



  • Drug of abuse testing companies

  • Drug of abuse testing reagent Manufacturers

  • Hospitals and Clinics

  • Diagnostics Centers

  • National Organizations & Government Organizations

  • Academic research institutes

  • Government institutes


Key Players for Drug of Abuse Testing Market:                                            


Some of the key players in this market are: Roche Holding Limited, Quest Diagnostics, Laboratory Corporation of America Holdings, Alere Inc, Abbott Laboratories, Randox Laboratories Ltd, Psychemedics Corporation, Bio-Rad Laboratories, Inc, Sonic Healthcare and Thermo Fisher Scientific Inc.


Study Objectives of the Market:



  • To provide detailed analysis of the market structure along with forecast for the next 9 years of the various segments and sub-segments of the drug of abuse testing market

  • To provide insights about factors affecting the market growth

  • To analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.

  • To provide forecast revenue of the market segments and sub-segments with respect to the main geography and various regions globally.

  • To provide regional level analysis of the market with respect to the current market size and future prospective

  • To provide regional level analysis of the market for segments by test type, by sample and its sub-segments.

  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market

  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global drug of abuse testing market.


Key Finding



  • The global drug of abuse testing market is expected to reach $3.0 billion in 2020, mainly driven by increased use of illicit drugs and need of drug abuse testing at organizational level.

  • Onsite testing market is more than double the size of laboratory testing due to ease of use, cost effectiveness and immediate results.

  • Urine followed by saliva is the most common specimen used in the drug of abuse testing. Hair as a specimen is also becoming a more effective way for testing long term drug use.

  • North America was the largest market by geography for drug abuse testing in 2014, with 76.4% share of the total market


Segments:


Global drug of abuse testing market is mainly segmented into test type and samples. Furthermore the test type is segmented into onsite screening test and laboratory drug testing. On the bases of samples the market is segmented into urine, hair, saliva and others.   


Regional Analysis of Drug of Abuse Testing Market:                                             


Globally Americas is the largest market for drug of abuse testing market. Europe is the second-largest for drug of abuse testing market. Europe drug of abuse testing market is expected to grow with a steady pace.


The report for Drug of Abuse Testing Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.

License
Single User Enterprise User (Buy Premium Reports Chapterwise)
Currency
TABLE OF CONTENTS

1.1 Market Definition

1.2 Market Breakdown by Type of Tests, Sample

1.3 Market Breakdown by Geography

1.4 Research Methodology and Sources

2.1 Key Findings

2.2 Research Summary

3.1 Introduction

3.1.1 International Drug Trafficking

3.1.2 Drug trafficking and illicit drug use in North America

3.1.3 Drug trafficking and illicit drug use in Europe

3.1.4 Drug trafficking and illicit drug use in Asia-Pacific

3.2 Technology Analysis – Drug Abuse Testing Market

3.2.1 Chromatography technology

3.2.2 Immunoassay technology

3.3 Single vis-à-vis Multiple Parameter Test

3.4 Factors Driving the Market and its Impact on Market Forecast

3.4.1 Increased use of drug testing at organizational level

3.4.2 Increased production and trade of illicit drugs worldwide

3.4.3 Global increase in road accidents and death rates

3.4.4 Increase in the consumption of illegal drugs

3.4.5 Impact analysis of drivers on market forecast

3.5 Factors Hindering the Market and its Impact on Market Forecast

3.5.1 Legalization of drugs

3.5.2 Social issues associated with drug abuse testing

3.5.3 Inability of testing products to detect low-dose designer drugs

3.5.4 Impact analysis of restraints on market forecast

4.1 Global Market Breakdown by Type of Test

4.2 Global Market Breakdown by Sample

4.3 Global Market Breakdown by Region

5.1 Onsite Testing

5.2 Laboratory Testing

5.3 The North American Market by Type of Test

5.3.1 U.S. drugs of abuse market by type of test

5.4 The European Market by Type of Test

5.4.1 The U.K. drugs of abuse market, by type of test

5.4.2 Germany drugs of abuse market by type of test

5.4.3 France drugs of abuse market, by type of test

5.5 The Asian Market by Type of Test

5.5.1 India drugs of abuse market by type of test

5.5.2 China drugs of abuse market, by type of test

5.5.3 Japan drugs of abuse market, by type of test

7.1 North America Market Breakdown by Country

7.1.1 Drug abuse market scenario in the U.S.

7.2 Europe Market Breakdown by Country

7.2.1 Drug abuse market scenario in the U.K.

7.2.2 Drug abuse market scenario in France

7.2.3 Drug abuse market scenario in Germany

7.3 Asia-Pacific Market Breakdown by Country

7.3.1 Drug abuse market scenario in India

7.3.2 Drug abuse market scenario in China

7.3.3 Drug abuse market scenario in Japan

.1 Porter's Five Forces of Competitive Position Analysis

8.1.1 Bargaining power of buyers

8.1.2 Bargaining power of suppliers

8.1.3 Threat of new entrants

8.1.4 Intensity of rivalry

8.1.5 Threat of substitutes

9.1 Roche Holding Limited

9.1.1 Business Overview

9.1.2 Products and Services

9.1.3 Recent Developments

9.2 Quest Diagnostics

9.2.1 Business Overview

9.2.2 Products and Services

9.2.3 Recent Developments

9.3 Laboratory Corporation of America Holdings

9.3.1 Business Overview

9.3.2 Products and Services

9.3.3 Recent Developments

9.4 Alere Inc.

9.4.1 Business Overview

9.4.2 Products and Services

9.4.3 Recent Developments

9.5 Abbott Laboratories

9.5.1 Business Overview

9.5.2 Products and Services

9.5.3 Recent Developments

9.6 Randox Laboratories Ltd

9.6.1 Business Overview

9.6.2 Products and Services

9.6.3 Recent Developments

9.7 Psychemedics Corporation

9.7.1 Business Overview

9.7.2 Products and Services

9.7.3 Recent Developments

9.8 Bio-Rad Laboratories, Inc.

9.8.1 Business Overview

9.8.2 Products and Services

9.8.3 Recent Developments

9.9 Sonic Healthcare

9.9.1 Business Overview

9.9.2 Products and Services

9.9.3 Recent Developments

9.1 Thermo Fisher Scientific Inc.

9.10.1 Business Overview

9.10.2 Products and Services

9.10.3 Recent Developments

10.1 List of Abbreviations

TABLE 1 SPECIFIC PRIMARY AND SECONDARY SOURCES USED FOR THIS PUBLICATION
TABLE 2 GLOBAL DRUG ABUSE TESTING MARKET SNAPSHOT (2015AND 2020)
TABLE 3 WORLDWIDE NUMBER OF ILLICIT DRUG USERS, BY MAJOR DRUGS, % SHARE (2011)
TABLE 4 MULTIPLE PARAMETER TEST ADVANTAGES OVER SINGLE PARAMETER TEST
TABLE 5 DRIVERS FOR THE MARKET: IMPACT ANALYSIS
TABLE 6 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
TABLE 7 GLOBAL MARKET BREAKDOWN BY TYPE OF TEST, $M (2011 – 2014)
TABLE 8 GLOBAL MARKET BREAKDOWN BY TYPE OF TEST, $M (2015 – 2020)
TABLE 9 GLOBAL MARKET BREAKDOWN BY SAMPLE, $M (2011 – 2014)
TABLE 10 GLOBAL MARKET BREAKDOWN BY SAMPLE, $M (2015 – 2020)
TABLE 11 GLOBAL MARKET BREAKDOWN BY REGION, $M (2011 – 2014)
TABLE 12 GLOBAL MARKET BREAKDOWN BY REGION, $M (2015 – 2020)
TABLE 13 ONSITE SCREENING TEST – ADVANTAGES AND DISADVANTAGES
TABLE 14 LABORATORY DRUG TEST - ADVANTAGES AND DISADVANTAGES
TABLE 15 NORTH AMERICA MARKET BREAKDOWN BY TYPE OF TEST, $M (2011 – 2014)
TABLE 16 NORTH AMERICA MARKET BREAKDOWN BY TYPE OF TEST, $M (2015 – 2020)
TABLE 17 U.S. MARKET BREAKDOWN BY TYPE OF TEST, $M (2011 – 2014)
TABLE 18 U.S. MARKET BREAKDOWN BY TYPE OF TEST, $M (2015 – 2020)
TABLE 19 EUROPE MARKET BREAKDOWN BY TYPE OF TEST, $M (2011 – 2014)
TABLE 20 EUROPE MARKET BREAKDOWN BY TYPE OF TEST, $M (2015 – 2020)
TABLE 21 THE U.K. MARKET BREAKDOWN BY TYPE OF TEST, $M (2011 – 2014)
TABLE 22 THE U.K. MARKET BREAKDOWN BY TYPE OF TEST, $M (2015 – 2020)
TABLE 23 GERMANY MARKET BREAKDOWN BY TYPE OF TEST, $M (2011 – 2014)
TABLE 24 GERMANY MARKET BREAKDOWN BY TYPE OF TEST, $M (2015 – 2020)
TABLE 25 FRANCE MARKET BREAKDOWN BY TYPE OF TEST, $M (2011 – 2014)
TABLE 26 FRANCE MARKET BREAKDOWN BY TYPE OF TEST, $M (2015 – 2020)
TABLE 27 ASIA MARKET BREAKDOWN BY TYPE OF TEST, $M (2011 – 2014)
TABLE 28 ASIA MARKET BREAKDOWN BY TYPE OF TEST, $M (2015 – 2020)
TABLE 29 INDIA MARKET BREAKDOWN BY TYPE OF TEST, $M (2011 – 2014)
TABLE 30 INDIA MARKET BREAKDOWN BY TYPE OF TEST, $M (2015 – 2020)
TABLE 31 CHINA MARKET BREAKDOWN BY TYPE OF TEST, $M (2011 – 2014)
TABLE 32 CHINA MARKET BREAKDOWN BY TYPE OF TEST, $M (2015 – 2020)
TABLE 33 JAPAN MARKET BREAKDOWN BY TYPE OF TEST, $M (2011 – 2014)
TABLE 34 JAPAN MARKET BREAKDOWN BY TYPE OF TEST, $M (2015 – 2020)
TABLE 35 SAMPLE ANALYSIS – ADVANTAGES AND DISADVANTAGES
TABLE 36 NORTH AMERICA MARKET BREAKDOWN BY REGION, $M (2011 – 2014)
TABLE 37 NORTH AMERICA MARKET BREAKDOWN BY REGION, $M (2015 – 2020)
TABLE 38 EUROPE MARKET BREAKDOWN BY REGION, $M (2011 – 2014)
TABLE 39 EUROPE MARKET BREAKDOWN BY REGION, $M (2015 – 2020)
TABLE 40 ASIA MARKET BREAKDOWN BY REGION, $M (2011 – 2014)
TABLE 41 ASIA MARKET BREAKDOWN BY REGION, $M (2015 – 2020)
TABLE 42 ROCHE HOLDINGS – KEY FACTS
TABLE 43 QUEST DIAGNOSTICS – KEY FACTS
TABLE 44 LABORATORY CORPORATION OF AMERICA HOLDINGS – KEY FACTS
TABLE 45 ALEREINC. – KEY FACTS
TABLE 46 ABBOTT LABORATORIES – KEY FACTS
TABLE 47 RANDOX LABORATORIES – KEY FACTS
TABLE 48 PSYCHEMEDICS CORPORATION – KEY FACTS
TABLE 49 BIO-RAD LABORATORIES – KEY FACTS
TABLE 50 SONIC HEALTHCARE – KEY FACTS
TABLE 51 THERMO FISHER SCIENTIFIC INC.– KEY FACTS

FIG 1 GLOBAL DRUG ABUSE TESTING MARKET SHARE BY TYPE OF TEST (2014)
FIG 2 GLOBAL DRUG ABUSE TESTING MARKET SHARE BY SAMPLE (2014)
FIG 3 GLOBAL DRUG ABUSE TESTING MARKET SHARE BY REGION (2014)
FIG 4 GLOBAL DRUG ABUSE TESTING MARKET SHARE BY TYPE OF TEST (2014)
FIG 5 THE NORTH AMERICAN DRUG ABUSE TESTING MARKET SHARE BY TYPE OF TEST (2015)
FIG 6 THE EUROPEAN DRUG ABUSE TESTING MARKET SHARE BY TYPE OF TEST (2015)
FIG 7 THE ASIAN DRUG ABUSE TESTING MARKET SHARE BY TYPE OF TEST, 2015
FIG 8 GLOBAL DRUG ABUSE TESTING MARKET SHARE, BY SAMPLE, 2015
FIG 9 NORTH AMERICA DRUG ABUSE TESTING MARKET SHARE BY COUNTRY (2014)
FIG 10 EUROPE DRUG ABUSE TESTING MARKET SHARE BY COUNTRY (2014)
FIG 11 ASIA-PACIFIC DRUG ABUSE TESTING MARKET SHARE BY COUNTRY (2014)
FIG 12 PORTER’S FIVE FORCES OF COMPETITIVE POSITION ANALYSIS